Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, whose
treatment still has a major challenge of achieving a satisfactory curative effect. The …

Abstract N6-methyladenosine (m6A), one of the most common RNA methylation
modifications, has emerged in recent years as a new layer of the regulatory mechanism …

Abstract Methyltransferase‑like 3 (METTL3) is an RNA methyltransferase that mediates
modification of N6‑methyladenosine (m6A), which serves as an oncogene in various types …

Abstract N6-Methyladenosine (m6A) is the most common internal chemical modification of
mRNAs involved in many pathological processes including various cancers. In this study, we …

Abstract Background N6‐methyladenosine (m6A) modification may participate in the
regulation of occurrence and development of tumors. However, the m6A level and the …

N6‐Methyladenosine (m6A) modification is one of the commonest chemical modifications in
eukaryotic mRNAs, which has essential effects on mRNA translation, splicing, and stability …

Abstract N 6-methyladenosine (m 6 A) is the most common internal modification of mRNAs
in higher eukaryotic. This process is performed by methyltransferase. Methyltransferase-like …

Osteoporosis is a prevalent bone disease of the aging population, which is characterized by
a decrease in bone mass because of the imbalance of bone metabolism. Although the …

Abstract N6‑methyladenosine (m6A) RNA modification maintained by N6‑
methyltransferases and demethylases is involved in multiple biological functions …

Objectives Bone marrow mesenchymal stem cells (BMSCs) hold a high osteogenic
differentiation potential, but the mechanisms that control the osteogenic ability of BMSCs …